Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
drug delivery
Biotech
ReNeuron lays off 40% of staff to buy time for exosome pivot
The cuts extend the stem cell player’s cash runway out to 2024, partly easing the pressures that built up as it struggled to raise money last year.
Nick Paul Taylor
Jan 19, 2023 8:25am
Bionaut Labs secures $43M for its tiny, drug-carrying robots
Nov 28, 2022 11:48am
MIT robotic pill burrows through intestine's drug-blocking mucus
Oct 3, 2022 7:15am
MIT engineers develop shape-shifting artificial pancreas implant
Aug 8, 2022 10:28am
BD tightens guidance after completing Embecta diabetes spinoff
May 5, 2022 11:24am
Cloaking bacteria via tunable gene circuits for cancer treatment
Mar 21, 2022 10:55am